BATS BZX Real-Time Price
As of 9:30am ET
| +0.24 / +1.52%|
The 8 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 16.00. The median estimate represents a +25.08% increase from the last price of 15.99.
The current consensus among 8 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.